Silent threat: study to uncover hidden spread of brain infection in cambodian kids
NCT ID NCT06674837
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 4,000 children in Cambodia to understand how common Japanese Encephalitis (JE) is and how often it spreads without symptoms. Researchers will compare healthy children with those hospitalized for fever and brain-related symptoms. The goal is to measure the true burden of JE and identify risk factors, which could help improve future prevention efforts.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide crucial data on how Japanese Encephalitis spreads and affects children in Cambodia, guiding future prevention and control strategies.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly help sick children. Results may not apply to other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 4,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
see eligibility
- Ages
-
2 to 14 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Cohort 1 * All children aged between 2 and 14 years. * No fever or history of fever in the past 14 days. * Consenting to return to the hospital for follow-up visits. * Consenting to blood sampling. * Written informed assent/consent to participate in the study. Cohort 2 * Hospitalized patients aged between 2 and 14 years. * Any neurological disorder. * Any fever within the past 72 hours. * Written informed assent/consent to participate in the study. * No contraindication for lumbar puncture (LP).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Japanese encephalitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.